WallStreetZenWallStreetZen

NASDAQ: KALV
Kalvista Pharmaceuticals Inc Stock Ownership - Who owns Kalvista Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kalvista Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2025-12-087,294$16.51
$120.42kSell
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2025-11-2410,940$13.45
$147.15kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2025-11-245,296$13.45
$71.24kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2025-11-244,331$13.45
$58.26kSell
Brian PiekosChief Financial Officer2025-11-244,471$13.45
$60.14kSell
Nicole SweenyChief Commercial Officer2025-11-243,813$13.45
$51.29kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2025-11-2087,390$0.00
$349.56Buy
Benjamin L. PalleikoCHIEF EXECUTIVE OFFICER2025-11-184,466$14.48
$64.66kSell
Christopher YeaCHIEF DEVELOPMENT OFFICER2025-11-182,683$14.48
$38.85kSell
Paul K. AudhyaCHIEF MEDICAL OFFICER2025-11-183,075$14.48
$44.52kSell

1 of 5

KALV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KALV insiders and whales buy or sell their stock.

KALV Shareholders

What type of owners hold Kalvista Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vivo Ventures VI LLC16.64%8,409,126$125.30MInsider
Vr Adviser LLC13.31%6,728,985$100.26MInstitution
Venrock Healthcare Capital Partners III LP10.49%5,303,985$79.03MInsider
Tang Capital Management LLC9.97%5,041,798$75.12MInstitution
Frazier Life Sciences Management LP9.97%5,039,867$75.09MInstitution
Suvretta Capital Management LLC9.43%4,768,712$71.05MInstitution
Interwest Management Partners IX LLC9.14%4,619,196$68.83MInsider
Guy P. Nohra8.59%4,343,550$64.72MInsider
Acmp IV LLC8.59%4,343,550$64.72MInsider
Capital World Investors6.29%3,177,587$47.35MInstitution

1 of 3

KALV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KALV58.99%41.01%Net BuyingNet Buying
NKTR36.91%63.09%Net SellingNet Selling
GYRE1.87%98.13%Net Buying
MDXG46.43%53.57%Net Buying
ABUS29.81%70.19%
View Top Biotech Stocks

Kalvista Pharmaceuticals Stock Ownership FAQ

Who owns Kalvista Pharmaceuticals?

Kalvista Pharmaceuticals (NASDAQ: KALV) is owned by 116.00% institutional shareholders, 80.64% Kalvista Pharmaceuticals insiders, and 0.00% retail investors. Vivo Ventures VI LLC is the largest individual Kalvista Pharmaceuticals shareholder, owning 8.41M shares representing 16.64% of the company. Vivo Ventures VI LLC's Kalvista Pharmaceuticals shares are currently valued at $125.30M.

If you're new to stock investing, here's how to buy Kalvista Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.